Girl dies after fever outbreak at Mandla school
Officials confirmed that six samples are being sent for Japanese Encephalitis (JE) testing, even as most of the affected children are reported stable.
The girl, identified as 15-year-old Shilpa Maravi, collapsed during a cultural programme on Independence Day. She was first admitted to Mandla district hospital and later shifted to Jabalpur Medical College in a critical state. Doctors earlier said she developed blood clots in the brain.
According to Mandla collector Somesh Mishra, all protocols are being followed to ascertain the cause of death. "The protocols in the postmortem examination were followed. It is essential to determine the cause of death. Other children with fever have had their samples taken. About 10–12 children have gone home, and 34 children are still here. One child was referred and she died during treatment. That's why videography is being done along with complete protocol.
by Taboola
by Taboola
Sponsored Links
Sponsored Links
Promoted Links
Promoted Links
You May Like
TV providers are furious: this gadget gives you access to all channels
Techno Mag
Learn More
Undo
Samples are being sent for testing. We will keep the JE aspect in mind too," Mishra told TOI.
Dr Sanjay Mishra, joint director (health), Jabalpur division, said the girl's body was taken away by her family. "She was on ventilator support but was taken to Nagpur by her kin on Sunday evening. They reportedly tried at two or three hospitals, but she was declared dead. They then took her to their residence in Niwas, Mandla. We have sought samples of six affected children from Mandla, which will be tested for JE," he said.
Officials have confirmed that preliminary dengue and malaria tests of the Mandla students returned negative, and the illness is currently suspected to be viral.
The episode has triggered concern in tribal Mandla and adjoining Dindori, where a six-year-old boy died on Aug 10 with suspected JE infection. That death could not be officially confirmed as no second test was carried out, but the back-to-back cases have raised fears of the mosquito-borne virus re-emerging in Madhya Pradesh after a gap of five years.
Stay updated with the latest local news from your
city
on
Times of India
(TOI). Check upcoming
bank holidays
,
public holidays
, and current
gold rates
and
silver prices
in your area.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
25 minutes ago
- Time of India
Rising MRSA superbug infections among fitness enthusiasts in the US and UK: Risks and prevention
Fitness enthusiasts in the US and UK may want to take a closer look at their gym hygiene habits. A recent report from the UK Health Security Agency ( UKHSA ) and a study published in NIH has raised a red flag about the rising spread of MRSA superbugs in community settings, particularly in gyms, health clubs, and other shared fitness spaces. MRSA, or Methicillin-resistant Staphylococcus aureus, is a type of bacteria resistant to many antibiotics, making it difficult to treat and potentially dangerous. What's especially alarming is that even healthy, active individuals are at risk. MRSA can survive on shared equipment, locker room benches, gym mats, towels, and other high-touch surfaces. Combine that with sweat, skin-to-skin contact, and poor cleaning practices, and you've got a perfect breeding ground for infection. The report shows a notable rise in MRSA cases among people under 45, many of whom regularly visit fitness centers. This surge in community-associated MRSA infections is a wake-up call for gym-goers to prioritize hygiene. Simple steps like wiping down equipment, using personal towels, wearing footwear in locker rooms, and avoiding direct contact with shared surfaces can go a long way in protecting yourself and others. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Mr. Bala's Powerful Intraday Strategy Revealed – No More Guesswork TradeWise Learn More Undo Fitness should strengthen you, not expose you to unnecessary health risks. Understanding MRSA superbugs and their impact on fitness enthusiasts Superbugs, or antibiotic-resistant bacteria, are a growing public health concern. These bacteria have evolved to withstand multiple antibiotics, making infections increasingly difficult to treat. One environment that can unknowingly contribute to the spread of these dangerous microbes is the fitness center. Gyms are communal spaces where people frequently share equipment, come into close physical contact, and perspire heavily, all of which create ideal conditions for bacterial transmission. One of the most well-known superbugs, MRSA (methicillin-resistant Staphylococcus aureus), is commonly found on skin and can spread through contaminated surfaces. When gym-goers fail to clean machines or mats after use, bacteria can easily transfer from person to person. Even small cuts or abrasions, common during workouts, can become entry points for these infections. Adding to the risk, bacteria like MRSA can survive for days on surfaces such as dumbbells, benches, and yoga mats. Moist environments like locker rooms and showers also promote bacterial growth, further increasing the chances of exposure. Preventing the spread of superbugs in gyms requires shared responsibility. Fitness centers should regularly disinfect equipment and facilities, and provide hand sanitizers and cleaning supplies. Gym members should also practice good hygiene, washing hands, wiping down machines, using towels as barriers, and avoiding workouts if they have open wounds or skin infections. As superbugs become more resistant to treatments, it's crucial to limit their spread in everyday environments like gyms. A clean, mindful workout space helps protect everyone's health. Key findings from recent studies on MRSA superbugs Study 1: A study conducted in the Memphis metropolitan area by NIH , found a high prevalence of multi-drug-resistant MRSA strains on surfaces in fitness centers. The research underscores the role of inanimate surfaces as potential sources of transmission. Study 2: Research from the UK Health Security Agency indicates a rise in community-associated MRSA infections, particularly among individuals under 45, many of whom are active in sports and fitness activities. Preventive measures and recommendations for MRSA superbug infections To effectively reduce the risk of superbug infections in fitness centers and other shared environments, health experts advise taking a proactive approach to hygiene and safety. The following measures are essential for both gym-goers and facility operators: Regularly disinfect gym equipment: All shared equipment, including weights, treadmills, benches, yoga mats, and exercise balls should be thoroughly cleaned with approved disinfectant wipes or sprays both before and after use. This helps eliminate harmful bacteria that may linger on surfaces for hours or even sharing personal items: Items such as towels, water bottles, razors, and clothing should never be shared. These can easily harbor and transfer bacteria from one person to another, especially in warm and humid gym environments. Cover all cuts, wounds, or abrasions: Open skin, even small nicks or blisters, can serve as entry points for bacteria like MRSA. Always use clean, waterproof bandages and avoid exposing broken skin to shared equipment or surfaces. Practice consistent personal hygiene: Wash your hands thoroughly with soap and water before and after workouts. If handwashing isn't possible, use an alcohol-based hand sanitizer. Shower promptly after exercising, especially if you've used communal areas like locker rooms, saunas, or pools. Wear proper footwear: Always wear flip-flops or shower shoes in communal showers and locker rooms to prevent contact with bacteria on wet surfaces. Report and avoid unsanitary conditions: If gym facilities appear unclean or lack proper sanitization supplies, inform staff or consider using a different location. While the rise of superbug infections is undoubtedly concerning, it is not a cause for panic but rather a call to action. By adopting proper hygiene practices, being mindful of personal and shared cleanliness, and remaining vigilant in fitness environments, individuals can play a key role in minimizing the spread of antibiotic-resistant bacteria. Simple actions like disinfecting equipment, covering wounds, and washing hands can make a significant difference. Fitness enthusiasts are encouraged to stay informed, take personal responsibility, and contribute to a safer, healthier gym experience for everyone. Proactive prevention today can help protect our health tomorrow. Also read| When being too healthy becomes unhealthy: 3 daily habits that can damage your body long-term
NDTV
31 minutes ago
- NDTV
World Mosquito Day 2025: Diseases Beyond Malaria That Indians Should Watch
Every year on 20 August, World Mosquito Day reminds us of Sir Ronald Ross's discovery that mosquitoes transmit malaria. But in 2025, the message goes far beyond malaria alone. These tiny insects remain one of the world's deadliest creatures, spreading a range of viral and parasitic diseases that affect millions in India each year. From dengue and chikungunya to Japanese encephalitis and lymphatic filariasis, mosquito-borne infections place huge health and economic burdens on families. India has made real strides against malaria, yet other mosquito-borne infections are seasonal regulars, especially during and after the monsoon. Knowing the symptoms, the national response and simple prevention steps can help you and your family stay safe. So, here's a brief but detailed guide on all the mosquito-borne infections that every Indian needs to be prepared to prevent and fight. Malaria: Progress, but don't drop your guard India has cut malaria sharply since 2015, and the National Strategic Plan aims to eliminate it in phased fashion by 2027-2030. Official surveillance recorded 227,564 cases and 83 deaths in 2023, reflecting a long-term decline, though hotspots persist in parts of tribal, forested and hard-to-reach areas. Use of rapid testing, artemisinin-based therapies, insecticide-treated nets and indoor residual spraying remain the pillars. If you develop fever with chills, test early, because malaria is curable when treated promptly. Dengue: India's biggest viral mosquito threat Driven by Aedes mosquitoes that breed in clean, stagnant water (rooftop tanks, coolers, planters), dengue now affects most districts. NCVBDC 's dashboard shows large annual swings and recent surges; 2024 saw very high counts and 2025 has already logged cases across multiple states as per very recent reports. Warning signs of dengue fever include high fever, intense body pain, retro-orbital headache, rash, and-around day 4-6-abdominal pain or bleeding. Management is mainly supportive; avoid NSAIDs like ibuprofen unless told by a clinician. Prevention is about community clean-ups (weekly "dry day"), covered water storage, and daytime bite protection. Chikungunya: Painful, usually self-limiting-still worth avoiding Also spread by Aedes, chikungunya causes sudden fever and severe joint pains that can linger for weeks. India documents cyclical spikes; NCVBDC maintains year-wise data and advisories for states. Treatment is supportive (fluids, rest, analgesics as advised). The same source reduction and daytime repellent strategies that work for dengue work here too-because it's the same mosquito. Japanese Encephalitis (JE): Less common but serious, with a vaccine in endemic areas JE is a brain infection caused by a flavivirus usually spread by Culex mosquitoes that breed near rice fields and pig-rearing areas. Most infections are asymptomatic, but severe disease can cause seizures, coma or neurological disability. There's no specific antiviral, so prevention is key. India offers JE vaccination to children in endemic districts through the Universal Immunization Programme; states in the North-East and East report most cases. Seek urgent care for fever with altered sensorium or seizures. Lymphatic Filariasis (LF/Elephantiasis): A long fight we can win Caused by thread-like worms spread by Culex (and some Anopheles/Aedes) mosquitoes, LF can silently damage lymphatic vessels and later lead to leg/genital swelling and disability. India is accelerating elimination using Mass Drug Administration (MDA)-an annual dose (DEC + albendazole), with triple-drug IDA (ivermectin + DEC + albendazole) in selected districts to speed up impact. The Government's 2024 updated guideline notes that about 40% of endemic districts have already stopped MDA after meeting microfilaria targets, and a national MDA round across 13 states launched in February 2025 to reach 17.5 crore people. If an MDA team visits, take the medicines under supervision unless you're medically ineligible-it protects you and your community. Zika: Still sporadic, but on the radar Zika causes a mild illness in most adults (fever, rash, red eyes, joint pains), but infection in pregnancy can cause serious birth defects. India reported 151 laboratory-confirmed Zika cases in 2024-the majority from Pune district, Maharashtra-prompting central advisories and a published national action plan. Pregnant women and couples planning pregnancy should be especially strict with bite prevention and should seek testing if symptomatic and exposed. West Nile Virus (WNV): Rare, yet documented in India WNV is a Culex-borne flavivirus; most infections are mild, but a small fraction progress to neuroinvasive disease. India has documented WNV activity for decades, with reports from Assam and Kerala among others, and research updates in peer-reviewed journals. If someone develops encephalitis during peak mosquito season, clinicians may test for WNV alongside JE. Where India Stands In 2025 Here's a brief report on the preparedness of the Indian healthcare system against these mosquito-borne illnesses, and what areas we need to highlight in each case. Malaria: Sustained decline in cases have been seen since 2015; 2023 recorded around 2.28 lakh cases and 83 deaths nationally, with elimination targeted by 2027-2030. Keep up testing and vector control in residual hotspots. Dengue & Chikungunya: Widely distributed prevalence across the nation. The Centre and states issue seasonal advisories and run source-reduction drives. Community participation is decisive with efforts like weekly dry days, covering tanks, and eliminating breeding sites. JE: Vaccination of children in endemic districts continues; surveillance tracks cases and deaths state-wise. Prompt referral of acute encephalitis syndrome (AES) saves lives. LF: India is aiming for elimination as a public-health problem by 2027. Updated national guidelines (2024) and large-scale MDA rounds (2025) are in place-public compliance with supervised dosing is critical. Zika & WNV: Sporadic threat but real; 2024 Zika clusters were confirmed by WHO, and WNV has documented circulation. Travel, pregnancy planning, and clinician awareness matter. What You Can Do (Works For All Mosquito-Borne Diseases) Here are some critical steps each and every Indian citizen needs to take to prevent all mosquito-borne illnesses. Stop breeding at home: Once a week, empty, scrub and sun-dry containers; cover tanks and buckets; change cooler water; drill holes in tyre swings; clear roof gutters. These steps hit Aedes hard. Use bite barriers: Wear long sleeves and trousers; apply EPA/WHO-recommended repellents (DEET, picaridin, IR3535). Sleep under long-lasting insecticidal nets in malaria-prone areas. Seek care early: Fever with severe body pain (think dengue/chikungunya), fever with chills (think malaria), or fever with confusion/seizures (think JE/WNV) needs quick medical attention. Public hospitals follow national protocols and testing algorithms. Say yes to public programmes: If your area runs JE vaccination or LF MDA, participate. These are proven, free and safe when you're eligible. India is steadily reducing malaria and pushing hard on LF, while tackling dengue, chikungunya and JE through vaccination, surveillance and vector control. But success depends on millions of small, weekly actions at household level, especially during monsoon. Stay alert, drain that water, and protect every bite.
Time of India
an hour ago
- Time of India
US FDA approves a weight loss drug for treating ‘serious' fatty liver disease; here's what you need to know
The US Food and Drug Administration (FDA) has officially approved semaglutide, a drug widely known for weight loss and diabetes control, for treating metabolic associated steatohepatitis (MASH). This approval marks a major advancement in liver disease treatment, as MASH is a progressive condition caused by fat buildup and inflammation in the liver. Often symptomless in its early stages, the disease can silently progress to cirrhosis, liver failure, or liver cancer if untreated. By targeting both weight reduction and liver health, semaglutide offers a dual benefit for patients at high risk. Experts see this as a breakthrough, providing the first effective pharmacological option for millions affected by fatty liver disease, which is rapidly emerging as a global health concern. These results suggest semaglutide is not just managing risk factors like weight and blood sugar but is directly improving liver health, offering new hope for patients who previously had no effective drug treatment options. What is the link between fatty liver and diabetes mellitus? What is MASH? Understanding the fatty liver disease MASH (previously called non-alcoholic steatohepatitis or NASH) is a severe form of fatty liver disease. It usually begins as metabolic-associated fatty liver disease (MAFLD), where fat gradually builds up in the liver due to poor metabolism. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Many Filipinos don't know about this! Read More Undo Early stage (MAFLD): Excess fat is stored in the liver but often without symptoms. Progression to MASH: Over time, fat accumulation triggers inflammation and cell injury. Advanced stage (Fibrosis and Cirrhosis): Continuous inflammation leads to scarring (fibrosis), which reduces liver function. Severe scarring, known as cirrhosis, may result in liver failure or cancer. Why early detection is difficult Most patients remain unaware of MASH because symptoms develop only in later stages. When present, they may include: Abdominal discomfort or pain Fatigue and low energy Loss of appetite and weight loss Jaundice (yellowing of eyes and skin) This makes screening and preventive treatment crucial, especially for people who are overweight, diabetic, or have high cholesterol. MASH and obesity: How Semaglutide is changing liver disease treatment MASH is closely linked to obesity, diabetes, and metabolic syndrome. With the rise of these conditions globally, MASH has become one of the leading causes of chronic liver disease. Until recently, doctors only recommended lifestyle interventions such as diet control, weight loss, and regular exercise. In 2023, the FDA approved Resmetirom, the first medicine for MASH. Now, semaglutide's approval adds another option — but with a different working mechanism. Semaglutide belongs to a class of drugs known as GLP-1 receptor agonists. It was first approved in 2017 for type 2 diabetes and later for obesity management and heart disease prevention. In MASH patients, semaglutide helps by: Reducing body weight and abdominal fat, which lowers liver fat storage Improving insulin resistance, a key factor in fatty liver buildup Lowering systemic inflammation, reducing liver injury This makes semaglutide particularly useful in patients who have both obesity and fatty liver disease. Source: The New York Times FDA approves semaglutide medication for MASH after strong clinical trial results The FDA based its approval on results from a large phase III clinical trial involving 800 participants across multiple centers. 534 patients received semaglutide; 266 received a placebo. After 72 weeks, results showed: 63% of patients on semaglutide had resolution of MASH without worsening liver scarring. Only 34% in the placebo group achieved the same. When looking at liver fibrosis (scarring): 37% of semaglutide users showed improvement, compared to 22% in the placebo group. The trial is ongoing for 240 weeks (around 4.5 years) to determine whether these improvements can lower risks of death, liver transplant, or severe complications. MASH in India: A growing health challenge India is witnessing a rapid increase in metabolic liver diseases, driven by rising obesity, sedentary lifestyles, and high rates of diabetes. As reported, studies estimate that 9% to 32% of Indians may be living with MAFLD, the starting point of MASH. A 2025 study of IT employees in Hyderabad revealed alarming trends: 84% had excess liver fat 76.5% had high cholesterol levels 70.7% were obese 20.9% had elevated fasting blood sugar These numbers reflect the strong connection between urban lifestyles, poor diet, and fatty liver disease in India's working population. Also Read |
